Clinical Trials Browser

Phase 1/2 × Has results × Thymoma × Clear all

NCT01100944 2017-08-10

A Phase 1/2 Study of PXD101 (Belinostat) in Combination With Cisplatin, Doxorubicin and Cyclophosphamide in the First Line Treatment of Advanced or Recurrent Thymic, Malignancies

Phase 1/2 Terminated

26 enrolled 33 charts

Thymoma, Thymus Neoplasms